Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh

Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh

Introduction: Mucormycosis is associated with high mortality (45–90%) in average-income countries including India. Prevention of mucormycosis associated with coronavirus disease 2019 (COVID-19) or in patients recovering from COVID-19 needs a further understanding on epidemiology and underlying risk...

Full description

Bibliographic Details
Main Authors: Venkata Vijayasekhar Manda, Manoj Patruni, M PA Babu Nagendra, M Swatantra Bharthi, Vivek Nagappa, Hema Swaroop Kurumella
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
epidemiology
hyphae
mucormycosis
post-covid-19 patients
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6995;epage=7000;aulast=Manda

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6995;epage=7000;aulast=Manda

Similar Items